tm logo
B BEAUFORT
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 03 Mar 2017

Last Applicant/ Owned by

Attn.: John Rickman, Senior V.P.

NORFOLK

VA

23510

Serial Number

77602824 filed on 29th Oct 2008

Registration Number

3825880 registered on 27th Jul 2010

in the Principal Register

Correspondent Address

TIMOTHY J. LOCKHART

WILLCOX & SAVAGE P.C.

1 COMMERCIAL PL #1800

ATTN: IP ADMINISTRATOR

NORFOLK, VA 23510-2115

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

B BEAUFORT

Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals The mark consists of the letter "B" written in a circle with the word "Beaufort" written to the right of the circle and an arc appearing beneath the letter "B" and the word "Beaufort". Color is not claimed as a feature of the mark. RegulatRead More

Classification Information


Class [035]
Advertising, Business & Retail Services


Regulatory submission management, namely, assisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management


First Use Date in General

25th Jun 2009

First Use Date in Commerce

25th Jun 2009

Class [045]
Personal & Legal & Social Services


Legal research, namely, regulatory research in the pharmaceutical industry, biotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for others, namely, reviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceutical, veterinary, pharmacogenomic, biotechnical and medical products and devices; providing information relating to legal affairs, namely, providing regulatory information relating to the development and validation of drugs, devices and biologics; regulatory compliance consulting as it applies to clinical trials, namely, monitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation services, namely, preparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validation, namely, regulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvement, namely, providing independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research


First Use Date in General

25th Jun 2009

First Use Date in Commerce

25th Jun 2009

Class [040]
Treatment & Processing of Materials Services


Consulting services in the field of manufacturing compliance and validation, namely, providing technical advice related to the manufacture of pharmaceuticals


First Use Date in General

25th Jun 2009

First Use Date in Commerce

25th Jun 2009

Class [042]
Computer & Software Services & Scientific Services


Contract research organization (CRO) services, namely, monitoring of clinical trials for investigational drugs of biotech and pharmaceutical companies, clinical trial project management and quality assurance, medical writing of investigational drug protocols, and medical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trials, drug development, manufacturing environmental compliance and validation, advanced technology in the pharmaceutical field, and medical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international health, the pharmaceutical industry, the biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for others, namely, providing implementation services relating to the development and validation of drugs, devices and biologics


First Use Date in General

25th Jun 2009

First Use Date in Commerce

25th Jun 2009

Mark Details


Serial Number

No 77602824

Mark Type

No Service Mark

Attorney Docket Number

No 06887.000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

07.09.06 -

Triumphal arches, arches, porticos

26.01.21 -

Circles that are totally or partially shaded

Description of Design Search

The mark consists of the letter "B" written in a circle with the word "Beaufort" written to the right of the circle and an arc appearing beneath the letter "B" and the word "Beaufort".

Legal History


Show more

Status DateAction Taken
03rd Mar 2017CANCELLED SEC. 8 (6-YR)
20th Jun 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
20th Jun 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
27th Jul 2010REGISTERED-PRINCIPAL REGISTER
19th Jun 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
18th Jun 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
18th Jun 2010ASSIGNED TO LIE
03rd Jun 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
19th May 2010ASSIGNED TO EXAMINER
26th Apr 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL